CAS 1358715-18-0
:1(2H)-Phthalazinone, 4-[[3-[[5,6-dihydro-2-(trifluoromethyl)[1,2,4]triazolo[1,5-a]pyrazin-7(8H)-yl]carbonyl]-4-fluorophenyl]methyl]-
Description:
1(2H)-Phthalazinone, 4-[[3-[[5,6-dihydro-2-(trifluoromethyl)[1,2,4]triazolo[1,5-a]pyrazin-7(8H)-yl]carbonyl]-4-fluorophenyl]methyl]- is a complex organic compound characterized by its unique structural features, including a phthalazinone core and a trifluoromethyl-substituted triazolo-pyrazine moiety. This compound exhibits a range of chemical properties due to the presence of multiple functional groups, which can influence its reactivity and interactions with biological systems. The trifluoromethyl group enhances lipophilicity, potentially affecting its pharmacokinetics and bioavailability. Additionally, the presence of fluorine atoms can impart unique electronic properties, making it of interest in medicinal chemistry. The compound may exhibit biological activity, which could be explored for therapeutic applications, particularly in areas such as oncology or infectious diseases. Its synthesis and characterization would typically involve advanced organic chemistry techniques, and its stability and solubility would be critical factors in determining its practical applications. Overall, this compound represents a significant example of modern drug design, integrating multiple pharmacophores into a single molecular entity.
Formula:C22H16F4N6O2
Synonyms:- 1(2H)-Phthalazinone, 4-[[3-[[5,6-dihydro-2-(trifluoromethyl)[1,2,4]triazolo[1,5-a]pyrazin-7(8H)-yl]carbonyl]-4-fluorophenyl]methyl]-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
Fluzoparib
CAS:<p>Fluzoparib (SHR3162) is a novel, potent, and orally available inhibitor of PARP, potentially for the treatment of solid tumours.</p>Formula:C22H16F4N6O2Purity:98.53% - 99.63%Color and Shape:SolidMolecular weight:472.4
